Previous 10 | Next 10 |
2023-11-03 10:02:39 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in For further details see: Cellectis, VYNE Therapeutics among healthcare movers
A JDRF funded grant is being used to explore the combination of NexImmune’s antigen specific nanoparticles and an anti-CD3 mAb for prevention and treatment of type 1 diabetes GAITHERSBURG, Md., Oct. 24, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI) announces the ...
2023-10-19 13:03:05 ET Gainers: WeBuy Global Ltd ( WBUY ) +138% . SeaStar Medical Holding Corp ( ICU ) +36% . Spectral AI MDAI +32% . Palatin Technologies PTN +29% . Mmtec ( MTC ) +29% . Maison Solutions ( MSS ) +26% . Bi...
GAITHERSBURG, Md., Oct. 19, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncology, autoimmune and infectious diseases, today...
GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI) (the “Company”) a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncolo...
2023-10-03 07:23:19 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are a major topic this morning as we check out the biggest ones worth watching on Tuesday! Moving stocks this morning are share delistings, Q3 earnings estimates and...
2023-08-31 17:13:00 ET More on Neximmune Neximmune GAAP EPS of -$0.29 NexImmune stock surges ~55% on preclinical data linked to T cell response NexImmune gains aftermarket on IND clearance for NEXI-003 to treat HPV-related cancers NexImmune promotes insi...
Company retains core capabilities to continue to advance its nanoparticle injection (AIM INJ) platform and potential product candidates in oncology and autoimmune diseases GAITHERSBURG, Md., Aug. 31, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel app...
2023-08-11 16:12:17 ET More on Neximmune NexImmune stock surges ~55% on preclinical data linked to T cell response NexImmune gains aftermarket on IND clearance for NEXI-003 to treat HPV-related cancers NexImmune promotes insider Mathias Oelke to chief scientific...
NEXI-001 data presented at ASCO 2023 demonstrates proof-of-concept in patients with relapsed AML after allogeneic hematopoietic cell transplantation (HCT) and refractory to additional chemotherapy or salvage treatments; one patient continues to show no evidence of disease at nine months P...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...